Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Chemical Industry News Himadri Speciality Chemical invests in Sicona Battery Technologies Himadri Speciality Chemical, an Indian specialty chemical conglomerate, has made an investment of AUD 10.32 million in Sicona… byPallavi MadhirajuJune 4, 2023